The Future of Early-Stage Medtech Investing: A Global Outlook | LSI Europe '25

This Panel took place at LSI Europe ‘25 Emerging Medtech Summit in London.Leading venture capital experts from Solas BioVentures, Buenavista Equity Partners, Precision Life Science Partners, MedMountain Ventures, and Mercia Ventures examine global trends and opportunities in early-stage medical technology investments.This Panel featured:Dave Adair — Solas BioVenturesBibi Sattar Marques — Buenavista Equity Partners Nick Pachuda — Precision Life Science PartnersBranden Rosenhan — MedMountain VenturesRobert Hornby — Mercia VenturesJoin us at our next event: https://www.lifesciencemarketresearch.com/why-lsi-summitsFollow us on social:LinkedIn: https://www.linkedin.com/company/life-science-intelligence/Twitter: https://twitter.com/lsintelligenceInstagram: https://www.instagram.com/lifescienceintelligence/Facebook: https://www.facebook.com/LifeScienceIntelligence/Spotify: https://open.spotify.com/show/7LnmGOwBMmRHJeDXmv3KEI?si=a93200169a884c09Subscribe to our YouTube: https://www.youtube.com/channel/UCxAwCTpHCMTScEJbgW7Scjw

There are no comments yet.

Please log in to write the first comment.